StockGlow

Arno Therapeutics, Inc. (ARNI)

Develops experimental cancer drugs currently being tested in clinical trials.

$0.00+0.00%Healthcare
Compare ARNI with
StockGlow Score
3
Bearish
BearishBullish
1 year ago+0.0%

The outlook

ARNI is trading at its 52-week low with minimal analyst coverage. The stock sits well below both its 50- and 200-day moving averages, reflecting a sustained downtrend. Current market positioning shows weak technical momentum.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$4,934
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

FPMIFluoroPharma Medical, Inc.$0.00+0.00%AOLSAeolus Pharmaceuticals, Inc.$0.00+0.00%BZYRBurzynski Research Institute, Inc.$0.00+12.50%OVITOncoVista Innovative Therapies, Inc.$0.00+0.00%AMBSAmarantus BioScience Holdings, Inc.$0.00+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy